Zusammenfassung
Hintergrund
Bei retinalen Arterienastverschlüssen steht keine ausreichend wirksame Therapie zur Verfügung. Die transluminale Nd:YAG-Laser-Embolektomie (TYE) ist ein kontrovers diskutierter Therapieansatz. Mit dem Nd:YAG-Laser wird die Gefäßwand rupturiert und der Embolus in den Glaskörperraum geschleudert.
Methoden
Wir untersuchten retrospektiv die Ergebnisse von 5 mit dieser Methode behandelten Patienten.
Ergebnisse
Das Alter der Patienten lag zwischen 26 und 75 Jahren (Mittelwert 58, Median 68). Der Ausgangsvisus betrug Handbewegungen bis 1,0. Alle Patienten hatten Gesichtsfeldausfälle. Die Behandlung erfolgte zwischen 4 und 30 h nach Einsetzen der Symptome. In 2 Fällen kam es zu einem deutlichen Visusanstieg am Folgetag (Handbewegungen zu 0,8; 0,4 zu 1,0). Der Endvisus lag zwischen 0,8 und 1,25. In allen Fällen entstand eine Glaskörperblutung, die nur in einem Fall behandelt werden musste. Die Nachbeobachtungszeit betrug 4 bis 42 Monate.
Schlussfolgerung
Die Ergebnisse entsprechen den bisher veröffentlichten Fällen. Die TYE ist eine schnelle, einfache und jederzeit verfügbare Methode, die insbesondere bei schlechtem Ausgangsvisus in Erwägung gezogen werden sollte.
Abstract
Background
There is currently no effective therapy for retinal artery branch occlusion (RABO). Transluminal Nd:YAG embolectomy (TYE) was developed to achieve rapid reperfusion; however, it is still a subject of controversy. A Nd:YAG laser is focused on the occluded vessel, the vessel wall is ruptured and the embolism dislocates to the vitreous humor through the opening in the artery.
Method
We retrospectively examined the results of five patients treated with TYE.
Results
The age of the patients was 26–75 years (mean age 58 years, median 68 years). Initial visual acuity was hand movements to 1.0 and all patients had visual field defects. Treatment was performed between 4 and 30 h from the onset of symptoms. Visual acuity improved markedly in two cases the next day (hand movements to 0.8 and 0.4 to 1.0) and final visual acuity was between 0.8 and 1.25. All treatments led to vitreous hemorrhage but only one patient required surgical treatment. The range of follow-up was 4–42 months.
Conclusions
The results are in accordance with those published in the literature. It can be concluded that TYE is a fast, easy and readily available method that should be taken into account especially in cases with low initial visual acuity.
Literatur
Borah N (2003) Is there really a correlation between transluminal Nd:YAG laser embolysis procedure for branch retinal artery occlusion and reperfusion as well as visual restoration? Retina 23:425 (author reply 425–426)
Feist RM, Emond TL (2005) Translumenal Nd:YAG laser embolysis for central retinal artery occlusion. Retina 25:797–799
Feltgen N, Neubauer A, Jurklies B et al (2006) Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950–956
Haritoglou C, Wolf A, Ulbig MW (2010) Laser embolectomy for central retinal artery occlusion. Ophthalmologe 107:465–467
Hayreh SS (2008) Restoration of retinal blood flow via translumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina 28:1369–1372 (author reply 1372–1373)
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 116:1188–1194
Hayreh SS, Zimmerman MB, Kimura A et al (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78:723–736
Lim JY, Lee JY, Chung HW et al (2009) Treatment of branch retinal artery occlusion with transluminal Nd:YAG laser embolysis. Korean J Ophthalmol 23:315–317
Lu N, Yang QS, Ma K et al (2006) Preliminary report of Nd: YAG laser embolysis for branch retinal artery occlusion. Zhonghua Yan Ke Za Zhi 42:326–329
Mason JO 3rd, Nixon PA, Albert MA Jr (2007) Trans-luminal Nd:YAG laser embolysis for branch retinal artery occlusion. Retina 27:573–577
Mason JO 3rd, Shah AA, Vail RS et al (2008) Branch retinal artery occlusion: visual prognosis. Am J Ophthalmol 146:455–457
Mueller AJ, Neubauer AS, Schaller U et al (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121:1377–1381
Opremcak E, Rehmar AJ, Ridenour CD et al (2008) Restoration of retinal blood flow via translumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina 28:226–235
Opremcak EM, Benner JD (2002) Translumenal Nd:YAG laser embolysis for branch retinal artery occlusion. Retina 22:213–216
Reynard M, Hanscom TA (2004) Neodymium:yttrium-aluminum-garnet laser arteriotomy with embolectomy for central retinal artery occlusion. Am J Ophthalmol 137:196–198
Ros MA, Magargal LE, Uram M (1989) Branch retinal-artery obstruction: a review of 201 eyes. Ann Ophthalmol 21:103–107
Selaru D, Radocea R, Stanca H (2008) Inferior temporal branch arterial occlusion – acute form. Oftalmologia 52:64–71
Shalchi MH, Daneshvar R (2009) Transluminal Nd:YAG laser embolysis in a case of hemiretinal arterial occlusion. East Mediterr Health J 15:1613–1616
Stanca HT, Balta F (2008) Transluminal embolysis with Yag-Nd-laser. Oftalmologia 52:77–80
Wolf S, Hoberg A, Bertram B et al (1989) Video fluorescein angiography follow-up of patients with retinal artery occlusion. Klin Monatsbl Augenheilkd 195:154–160
Yuzurihara D, Iijima H (2004) Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol 48:490–492
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
__ ____
Dieser Beitrag basiert auf einem Poster, vorgestellt auf dem DOG-Kongress 2012.
Rights and permissions
About this article
Cite this article
Much, M., Hesse, L. Behandlung retinaler Arterienastverschlüsse mittels transluminaler Nd:YAG-Laser-Embolektomie. Ophthalmologe 111, 144–150 (2014). https://doi.org/10.1007/s00347-013-2803-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-2803-4